Display Settings:

Format

Send to:

Choose Destination

    Oncogene. 1999 Nov 4;18(46):6183-90.

    Bis, a Bcl-2-binding protein that synergizes with Bcl-2 in preventing cell death.

    Lee JH, Takahashi T, Yasuhara N, Inazawa J, Kamada S, Tsujimoto Y.

    Department of Medical Genetics, Osaka University Graduate School of Medicine, Japan.

    Bcl-2 is the best characterized inhibitor of apoptosis, although the molecular basis of this action is not fully understood. Using a protein interaction cloning procedure, we identified a human gene designated as bis (mapped to chromosome 10q25) that encoded a novel Bcl-2-interacting protein. Bis protein showed no significant homology with Bcl-2 family proteins and had no prominent functional motif. Co-immunoprecipitation analysis confirmed that Bis interacted with Bcl-2 in vivo. DNA transfection experiments indicated that Bis itself exerted only weak anti-apoptotic activity, but was synergistic with Bcl-2 in preventing Bax-induced and Fas-mediated apoptosis. These results suggest that Bis is a novel modulator of cellular anti-apoptotic activity that functions through its interaction with Bcl-2.

    PMID: 10597216 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read